Skip to content

Net Income at other companies

IAR
Integra LifeSciencesIART
-$4.62M+81.7%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
-$20.91M+60.6%
Bioventus logo
BioventusBVS
$3.11M+218%
Artivion logo
ArtivionAORT
$1.42M+381%
Axogen logo
AxogenAXGN
-$19.58M-411%
LeMaitre Vascular logo
LeMaitre VascularLMAT
$15.68M+42.4%

Other financials

Income statement

See full
Revenue$37.2M-57.1%
Gross profit$63.0M-22.5%
Operating income-$68.9M-158%
EPS (diluted)-$0.44-159%

Balance sheet

See full
Cash & equivalents$91.4M-16.9%
Total debt$39.4M+24.8%
Total equity$244.6M+0.7%
Total assets$520.0M+11.3%

Cash flow

See full
Operating cash flow$21.1M+206%
CapEx$3.1M-13.2%
Free cash flow$18.0M+176%

Valuation

See full
Market cap$312.68M-23.7%
Enterprise value$260.72M-21.3%
P/E115×
P/S0.6×-0.3×

Profitability

See full
Gross margin75.9%+0.8pp
Operating margin0.5%
Net margin0.5%+0.3pp
FCF margin6.9%

Returns & leverage

See full
Return on equity1.1%+0.6pp
Debt / equity0.2×0.0×
Current ratio3.5×-0.6×

Where this comes from

Reported directly by Organogenesis Holdings Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: Organogenesis Holdings Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organogenesis Holdings Inc.'s net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Organogenesis Holdings Inc.'s net income?
Organogenesis Holdings Inc. (ORGO) reported net income of -$53.16M in Q1 2026.
How has Organogenesis Holdings Inc.'s net income changed year-over-year?
Organogenesis Holdings Inc.'s net income decreased by 182.1% year-over-year, from -$18.84M to -$53.16M.
What is the long-term trend for Organogenesis Holdings Inc.'s net income?
Over 3 years (2021 to 2025), Organogenesis Holdings Inc.'s net income has grown at a -26.7% compound annual growth rate (CAGR), from $94.2M to $37.03M.
What does net income mean?
The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.